Your browser doesn't support javascript.
COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
Wu, Yi-Feng; Yu, Wan-Jun; Jiang, Yu-Hua; Chen, Yin; Zhang, Bo; Zhen, Rui-Bing; Zhang, Jun-Tao; Wang, Yi-Ping; Li, Qiang; Xu, Feng; Shi, Yan-Jun; Li, Xian-Peng.
  • Wu YF; Department of Hepatobiliary and Pancreas Surgery, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Yu WJ; Department of Respiratory Disease and Critical Care Medicine, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Jiang YH; Department of Infectious Diseases, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Chen Y; Department of Infectious Diseases, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Zhang B; Department of Infectious Diseases, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Zhen RB; Department of Respiratory Disease and Critical Care Medicine, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Zhang JT; Department of Ophthalmology, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Wang YP; Department of Laboratory Medicine, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Li Q; Department of Radiology, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Xu F; Department of Gastroenterology, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China.
  • Shi YJ; Department of Hepatobiliary and Pancreas Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 315009, Zhejiang Province, China.
  • Li XP; Department of Infectious Diseases, The Affiliated People's Hospital of Ningbo University, Ningbo 315040, Zhejiang Province, China. rmlixianpeng@nbu.edu.cn.
World J Clin Cases ; 9(19): 5266-5269, 2021 Jul 06.
Article in English | MEDLINE | ID: covidwho-1314996
ABSTRACT

BACKGROUND:

Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B virus (HBV) reactivation occurring in COVID-19 patients has not yet been reported. CASE

SUMMARY:

A 45-year-old hepatitis B man with long-term use of adefovir dipivoxil and entecavir for antiviral therapy had HBV reactivation after being treated with methylprednisolone for COVID-19 for 6 d.

CONCLUSION:

COVID-19 or treatment associated immunosuppression may trigger HBV reactivation.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: World J Clin Cases Year: 2021 Document Type: Article Affiliation country: Wjcc.v9.i19.5266

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: World J Clin Cases Year: 2021 Document Type: Article Affiliation country: Wjcc.v9.i19.5266